project id: TCGA-PRAD; case submitter id: TCGA-ZG-A9L0; analyte type: DNA; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.76; rna integrity number: 8.3; age at index: 71; days to birth: -26055; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1942; age at diagnosis: 26055; ajcc clinical m: M0; ajcc pathologic n: N1; ajcc pathologic t: T3b; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 355.0; icd 10 code: C61; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; primary gleason grade: Pattern 5; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; secondary gleason grade: Pattern 4; site of resection or biopsy: Prostate gland; synchronous malignancy: No; tissue or organ of origin: Prostate gland; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 152; initial weight: 420.0; sample id: 7413d045-cedb-4ec6-95ea-6f7b676f800d; sample submitter id: TCGA-ZG-A9L0-01A; portion id: df6fce3f-1713-4bb0-996a-200e074a8a04; portion submitter id: TCGA-ZG-A9L0-01A-11; slide id: 280b1a28-e0da-4176-a302-be64aa1daea8; slide submitter id: TCGA-ZG-A9L0-01A-01-TSA; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 80.0; percent tumor nuclei: 90.0; section location: TOP;